The Hypoglycemic Effect of JinQi Jiangtang Tablets Is Partially Dependent on the Palmatine-Induced Activation of the Fibroblast Growth Factor Receptor 1 Signaling Pathway

• Main Authors: Siming Li (Author), Xiaoling Li (Author), HeMeng Wang (Author), Xinhang Jia (Author), Haoyang Mao (Author), Fangxin Dong (Author), Tingting Zhao (Author), Yuan Gao (Author), Chen Zhang (Author), Ruisong Bai (Author), Ruihao Liu (Author), Lijun Yan (Author), Yubin Ji (Author), Na Zhang (Author), Wenfei Wang (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

JinQi Jiangtang tablet (JQJTT) is a Chinese patent medicine that has been shown to be beneficial for patients with diabetes both preclinically and clinically; however, the molecular mechanism underlying the effects of JQJTT remains unclear. In this study, surface plasmon resonance fishing was employ...